Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. is dated May 16, 2025. The report serves to notify shareholders of the upcoming Annual General Meeting of Shareholders scheduled for June 23, 2025, at 3:00 p.m. Israel time at the company's offices in Ramat Gan, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding shareholder meeting logistics and does not contain financial performance data.
Material Changes
No material changes to financial operations or business strategy are reported in this filing. The document focuses solely on the administrative details of the shareholder meeting.
Guidance, Outlook, and Management Commentary
The filing includes no management commentary, financial guidance, or outlook. It does not disclose risks, contingencies, or unusual items. The primary content consists of the announcement of the meeting and the inclusion of three exhibits: the Notice and Proxy Statement, a Proxy Card for ordinary share holders, and a Voting Instruction Card for American Depositary Shareholders.
Key Facts for Investor Verification
- Annual General Meeting Date: June 23, 2025.
- Meeting Time: 3:00 p.m. Israel time.
- Meeting Location: 26 Ben Gurion Street, Ramat Gan, Israel.
- Voting Materials: Proxy cards and voting instruction cards are provided as exhibits for remote voting.
- Financial Data: None included in this specific filing.